Products standardized to PAC (≈36 mg/day). Sweetened juice provides little PAC and a lot of sugar.
Reduces recurrences in susceptible women; it does not work to treat an infection that is already active.
It is not a treatment: an active infection needs an antibiotic.
⏱ 3 min read
The cranberry is Vaccinium macrocarpon, a tart berry native to North America with documented traditional use among Native Americans for urinary tract infections and related disorders; European settlers adopted this use and, by the 20th century, North American sailors ate cranberries as part of their rations to prevent scurvy and urinary problems on long voyages; in recent decades, clinical research has partially supported the traditional use with data on the prevention of recurrent urinary tract infections in women, although with a more nuanced efficacy profile than the one promoted commercially.
The identified active principle is type A proanthocyanidins (A-PACs), a specific class of complex polyphenols with a peculiar chemical feature: they contain at least one double inter-flavanol bond that is practically exclusive to the cranberry and is responsible for the specific mechanism of action against uropathogenic Escherichia coli; A-PACs block bacterial adhesion to urinary epithelial cells by inhibiting bacterial P fimbriae (the appendages that allow attachment to the mucosa), thereby reducing initial colonization without the need for direct bactericidal activity.
The indication with the strongest clinical support is the prevention of recurrent urinary tract infections in premenopausal women: several meta-analyses have documented modest but significant reductions in incidence with supplementation at standardized doses over months, an indication recognized in several European guidelines as a first-line option alongside urinary hygiene, adequate hydration, and other non-antibiotic measures.
The most recent Cochrane meta-analysis (2023) concludes that cranberry reduces the risk of symptomatic urinary tract infection in women with recurrent infections by about 26 percent, with an excellent safety profile; the effects are smaller in other populations (older women, pregnant women, children, men), where the data are more limited or clearly negative.
In interstitial cystitis and overactive bladder, several small studies have documented symptomatic improvements with supplementation over months, an indication consistent with the mechanism of urinary mucosal protection and with some, though modest, clinical support.
In general cardiovascular health, several studies have shown modest improvements in lipid profile, endothelial function, and inflammatory markers with cranberry juice or extract consumption over several weeks; the effects are quantitatively smaller than those of specific pharmacological interventions but consistent with the general antioxidant and anti-inflammatory profile of polyphenol-rich berries.
In periodontitis and dental caries, cranberry A-PACs have shown in vitro inhibition of the adhesion of Streptococcus mutans (the main cariogenic bacterium) to dental enamel; some small studies have documented improvements in periodontal parameters with cranberry extract mouthwashes, an indication with interesting preliminary support.
The doses studied range from 250 to 500 milligrams daily of dry extract standardized to a minimum of 36 mg of type A proanthocyanidins (A-PACs) measured by the DMAC method, an important quantification because many commercial products do not meet this specification; traditional cranberry juice provides highly variable amounts of A-PACs depending on dilution, additives, and processing, and commercial "cocktail" products usually have very low concentrations and a lot of added sugar; the preventive effect appears gradually and requires continued use to be maintained.
Generally very well tolerated; the adverse effects described are rare and mild (mild digestive discomfort, occasionally diarrhea at high doses); people taking warfarin-type anticoagulants should be cautious because of a possible pharmacokinetic interaction that could raise the INR (the data are inconsistent but sufficient to justify monitoring); those with a history of calcium oxalate kidney stones should moderate consumption because cranberry provides significant amounts of oxalate; in pregnancy and breastfeeding it is generally considered safe at usual doses; in acute urinary tract infections, cranberry does not replace antibiotic treatment when it is clinically indicated, but is positioned as a preventive strategy in women with frequent recurrences.
Information, not medical advice. Scientific evidence reflects the quality of the studies.